Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $23.8500 (2.93%) ($22.7900 - $24.4900) on Mon. May. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.23% (three month average) | RSI | 81 | Latest Price | $23.8500(2.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.4% a day on average for past five trading days. | Weekly Trend | HALO advances 10.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(49%) IWM(45%) ARKG(43%) IWC(43%) | Factors Impacting HALO price | HALO will decline at least -2.115% in a week (0% probabilities). VIXM(-31%) VXX(-14%) UUP(-14%) TLT(-3%) IYT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.115% (StdDev 4.23%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
5 Day Moving Average | $23.23(2.67%) | 10 Day Moving Average | $22.64(5.34%) | 20 Day Moving Average | $20.51(16.28%) | To recent high | 0% | To recent low | 71.6% | Market Cap | $3.26b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |